Effects of gonadal and adrenal androgens in a novel androgen-responsive human osteoblastic cell line

Journal of Cellular Biochemistry

Volumn 71, Issue 1, 1998, Pages 96-108

  Hofbauer, Lorenz C ^a   Hicok, Kevin C ^a   Khosla, Sundeep ^a  

^a MAYO CLINIC   (United States)

Author keywords

Androgen receptor; Androgens; Antiandrogens; Differentiation; Osteoblasts; Proliferation

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; ANTIANDROGEN;

ARTICLE; BONE METABOLISM; CELL DIFFERENTIATION; CELL PROLIFERATION; HORMONAL REGULATION; HORMONE ACTION; HUMAN; HUMAN CELL; OSTEOBLAST; OSTEOPOROSIS; PRIORITY JOURNAL;

ADRENAL GLANDS; AGED; ALKALINE PHOSPHATASE; ANDROGEN ANTAGONISTS; ANDROGENS; CELL DIVISION; CELL LINE; COLLAGEN; DEHYDROEPIANDROSTERONE; DIHYDROTESTOSTERONE; DNA-BINDING PROTEINS; FLUTAMIDE; GENE EXPRESSION REGULATION; HUMANS; MALE; OSTEOBLASTS; OSTEOCALCIN; TESTOSTERONE; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032189236     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(19981001)71:1<96::AID-JCB10>3.0.CO;2-G     Document Type: Article

References (59)

1. Bagatell CJ, Bremner WJ (1996): Androgens in men: Uses and abuses. N Engl J Med 334:707-714.
2. Baran DT, Bergfeld MA, Teitelbaum SL, Avioli LV (1978): Effect of testosterone therapy on bone formation in an osteoporotic hypogonadal male. Calcif Tissue Int 25:103-106.
3. Behre HM, Kliesch S, Leifke E, Link TM, Nieschlag E (1997): Long-term effect of testosterone therapy on bone mineral density in hypogonadal men. J Clin Endocrinol Metab 82:2386-2390.
4. Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagos SC (1995): Regulation of interleukin-6, osteoclastogenesis, bone mass by androgens. The role of the androgen receptor. J Clin Invest 95:2886-2895.
5. Benz DJ, Haussler MR, Thomas MA, Speelman B, Komm BS (1991): High-affinity androgen binding and androgenic regulation of A1(I)-procollagen and transforming growth factor-beta steady state messenger ribonucleic acid levels in human osteoblast-like osteosarcoma cells. Endocrinology 128:2723-2730.
6. Benz WW, Getz MJ, Wells DL, Moses HL (1977): Nuclear RNA polymerase activities and poly (A)-containing mRNA accumulation in cultured AKR mouse embryo cells stimulated to proliferate. Exp Cell Res 108:157-165.
7. Bodine PVN, Riggs BL, Spelsberg TC (1995): Regulation of c-fos expression and TGF-β production by gonadal and adrenal androgens in normal osteoblastic cells. J Steroid Biochem Biol 52:149-152.
8. 3-responsive alkaline phosphatase in osteoblast-like cells (ROS 17/2.8, MG63, and MC 3T3) and growth cartilage cells in culture. J Biol Chem 264:11879-11886.
9. Canalis E, Raisz LG (1978): Effect of sex steroids on bone collagen synthesis in vitro. Calcif Tissue Int 25:105-110.
10. Carani C, Qin K, Simoni M, Faustini-Fustini M, Serpente S, Boyd J, Korach KS, Simpson ER (1997): Effect of testosterone and estradiol in a man with aromatase deficiency. N Engl J Med 337:91-95.
11. Chang CS, Kokontis J, Liao ST (1988): Molecular cloning of human and rat complementary DNA encoding androgen receptors. Science 240:324-326.
12. Colvard DS, Eriksen EF, Keeting PE, Wilson EM, Lubahn DB, French FS, Riggs BL, Spelsberg TC (1989): Identification of androgen receptors in normal human osteoblast-like cells. Proc Natl Acad Sci USA 86:854-857.
13. Czerwiec FS, Liaw JJ, Liu S-B, Perez-Stable C, Grumbles R, Howard GA, Roos BA, Burnstein KL (1997): Absence of androgen-mediated transcriptional effects in osteoblastic cells despite presence of androgen receptors. Bone 21:49-56.
14. Fedarko NS, Bianco P, Vetter U, Robey PG (1990): Human bone cell enzyme expression and cellular heterogeneity: correlation of alkaline phosphatase enzyme activity with cell cycle. J Cell Physiol 144:115-121.
15. Feinberg ALP, Vogelstein B (1983): A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13.
16. Finkelstein JS, Neer RM, Biller BMK, Crawford JD (1992): Osteopenia in men with a history of delayed puberty. N Engl J Med 326:600-604.
17. 3: Effects on normal rat bone cells. J Bone Miner Res 7:41-46.
18. Greenspan SL, Oppenheim DS, Klibanski A (1989): Importance of gonadal steroids to bone mass in men with hyperprolactinemic hypogonadism. Ann Intern Med 110: 526-531.
19. Harris SA, Enger RJ, Riggs BL, Spelsberg TC (1995a): Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10:178-186.
20. Harris SA, Tau KR, Enger RJ, Toft DO, Riggs BL, Spelsberg TC (1995b): Estrogen response in the hFOB 1.19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene. J Cell Biochem 59:193-201.
21. Hefferan TE, Rickard D, Waters KM, Roche P, Riggs BL, Spelsberg TC ( 1997): TGF-β inducible early gene (TIEG) overexpression mimics TGF-β action in human osteoblasts. J Bone Miner Res 12(suppl 1):S124 (abst 86).
22. Herrin DL, Schmidt GW (1988): Rapid, reversible staining of Northern blots prior to hybridization. BioTechniques 6:196-200.
23. Hofbauer LC, Hicok KC, Schroeder MJ, Harris SA, Robinson JA, Khosla S (1997): Development and characterization of a conditionally immortalized human osteoblastic cell line stably transfected with the human androgen receptor gene. J Cell Biochem 66:442-451.
24. Kasperk CH, Wergedal JE, Farley JR, Linkhart TA, Turner RT, Baylink DJ (1989): Androgens directly stimulate proliferation of bone cells in vitro. Endocrinology 124: 1576-1578.
25. Kasperk CH, Fitzsimmons R, Strong D, Mohan S, Jennings J, Wergedal J, Baylink DJ (1990): Studies of the mechanisms by which androgens enhance mitogenesis and differentiation in bone cells. J Clin Endocrinol Metab 71: 1322-1329.
26. 2. Calcif Tissue Int 58:376-382.
27. Kasperk C, Helmboldt A, Boercsoek I, Heuthe S, Cloos O, Niethardt F, Ziegler R (1997a): Skeletal site-dependent expression of the androgen receptor in human osteoblastic cell populations. Calcif Tissue Int 61:464-473.
28. Kasperk CH, Wakley GK, Hierl T, Ziegler R (1997b): Gonadal and adrenal androgens are potent regulators of human bone cell metabolism in vitro. J Bone Miner Res 12:464-471.
29. Kassem M, Okazaki R, De Leon D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL (1997): Potential mechanism of estrogen-mediated decrease in bone formation: Estrogen increases production of inhibitory insulin-like growth factor-binding protein-4. Proc Assoc Am Physician 108:155-164.
30. Lehrach H, Diamond D, Wozney JM, Boedtker H (1977): RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. Biochemistry 16:4743-4751.
31. Liesegang P, Romaldo G, Sudmann M, Wolf L, Schweikert H-U (1994): Human osteoblast like cells contain specific, saturable, high-affinity glucocorticoid, androgen, estrogen, and 1α,25-dihydroxycholecalciferol receptors. J Androl 15:194-199.
32. Lubahn DB, Joseph DR, Sar M, Tan J, Higgs HN, Larson RE, French FS, Wilson EM (1988): The human androgen receptor: Complementary deoxyribonucleic acid cloning, sequence analysis and gene expression in prostate. Mol Endocrinol 2:1265-1275.
33. Marie PJ (1994): Perspectives: Human osteoblastic cells: A potential tool to assess the etiology of pathologic bone formation. J Bone Miner Res 9:1847-1850.
34. Masuyama A, Ouchi Y, Sato F, Hosoi T, Nakamura T, Orimo H (1992): Characteristics of steroid hormone receptors in cultured MC3T3-E1 osteoblastic cells and effect of steroid hormones on cell proliferation. Calcif Tissue Int 51:376-381.
35. Migliaccio S, Davis VL, Gibson MK, Gray TK, Korach KS (1992): Estrogen modulates the responsiveness of osteoblast-like cells (ROS 17/2.8) stably transfected with estrogen receptor. Endocrinology 130:2617-2624.
36. Mizuno, Y, Hosoi T, Inoue S, Ikegami A, Kaneki M, Akedo Y, Nakamura T, Ouchi Y, Chang C, Orimo H (1994): Immunocytochemical identification of androgen receptor in mouse osteoclast-like multinucleated cells. Calcif Tissue Int 54:325-326.
37. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K (1995): Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 80:3689-3698.
38. Nakano Y, Morimoto I, Ishida O, Fujihara T, Mizokami A, Tanimoto A, Yanagihara N, Izumi F, Eto S (1994): The receptor, metabolism and effects of androgen in osteoblastic MC3T3-E1 cells. Bone Miner 26:245-259.
39. Ongphiphadhanakul B, Rajatanavin R, Chailurkit L, Piaseu N, Teerarungsikul K, Sirisriro R, Komindr S, Puavilai G (1995): Serum testosterone and its relation to bone mineral density and body composition in normal males. Clin Endocrinol 43:727-733.
40. Orwoll ES, Klein RF (1995): Osteoporosis in men. Endocr Rev 6:87-116.
41. Orwoll ES, Stribrska L, Ramsey EE, Keenan EJ (1991): Androgen receptors in osteoblast-like cell lines. Calcif Tissue Int 49:183-187.
42. Pilbeam CC, Raisz LG (1990): Effects of androgens on parathyroid hormone and interleukin stimulated prostaglandin production in culture neonatal mouse calvariae. J Bone Miner Res 5:1183-1188.
43. Riggs BL, Jowsey J, Goldsmith RS, Kelly PJ, Hoffman DL, Arnaud CD (1972): Short- and long-term effects of estrogen and synthetic anabolic hormone in postmenopausal osteoporosis. J Clin Invest 51:1659-1663.
44. Robey PG, Termine JD (1985): Human bone cells in vitro. Calcif Tissue Int 37:453-460.
45. Robinson JA, Harris SA, Riggs BL, Spelsberg TC (1997): Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 138:2919-2927.
46. Smith EP, Boyd J, Frank GR, Takahashi H, Cohen RM, Specker B, Williams TC, Lubahn DB, Korach KS (1994): Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 331:1056-1061.
47. Somjen D, Weisman Y, Harell A, Berger E, Kaye AM (1989): Direct and sex-specific stimulation by sex steroids of creatine kinase activity and DNA synthesis in rat bone. Proc Natl Acad Sci USA 86:3361-3365.
48. Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC (1995): Identification of a novel TGF-beta-regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 3:4907-4912.
49. Szelei J, Jimenez J, Soto AM, Luizzi MF, Sonnenschein C (1997): Androgen-induced inhibition of proliferation in human breast cancer MCF7 cells transfected with androgen receptor. Endocrinology 138:1406-1412.
50. Takeuchi M, Kakushi H, Tonkin M (1994): Androgens directly stimulate mineralization and increase androgen receptors in human osteoblast-like osteosarcoma cells. Biochem Biophys Res Commun 204:905-911.
51. Thomas PS (1980): Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. Proc Natl Acad Sci USA 77:5201-5205.
52. Tilley WD, Bentel JM, Aspinall JO, Hall RE, Horsfall DJ (1995): Evidence for a novel mechanism of androgen resistance in the human prostate cancer cell line, PC-3. Steroids 60:180-186.
53. Vanderschueren D, Bouillon R (1995): Androgens and bone. Calcif Tissue Int 56:341-346.
54. Watts CKW, King RJB (1994): Overexpression of estrogen receptor in HTB 96 human osteosarcoma cells results in estrogen-induced growth inhibition and receptor cross-talk. J Bone Miner Res 9:1251-1258.
55. Watts CKW, Parker MG, King RJB (1989): Stable transfection of the oestrogen receptor gene into a human osteosarcoma cell line. J Steroid Biochem 34:483-490.
56. Weisman Y, Cassorla F, Malozowski S, Krieg RJ, Goldray D, Kaye AM, Sömjen D (1993): Sex-specific response of bone cells to gonadal steroids: Modulation in perinatally androgenized females and in testicular feminized male rats. Steroids 58:126-133.
57. Wishart JM, Need AG, Horowitz M, Morris HA, Nordin BE (1995): Effect of age on bone density and bone turnover in men. Clin Endocrinol 42:141-146.
58. Yuan S, Trachtenberg J, Mills GB, Brown TJ, Xu F, Keating A (1993): Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. Cancer Res 53:1304-1311.
59. Zhuang YH, Blauer M, Pekki A, Tuohimaa P (1992): Subcellular location of androgen receptor in rat prostate, seminal vesicle and human osteosarcoma MG-63 cells. J Steroid Biochem Mol Biol 41:693-696.